Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

4 treatments under study, led by Left Lateral Orbital Injection Of Botox Cosmetic Or Dysport

Research Leaders

5 sponsors active, led by University of Regensburg

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

3Total
Not Applicable (2)
Phase 4 (1)

Trial Status

Completed3

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 3 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT00843323Not ApplicableCompleted

Photodynamic Therapy (PDT) Effect on Large Surface Photodamaged Skin

NCT01529788Phase 4Completed

Onabotulinum Toxin Type A and Abobotulinum Toxin Type A Crow's Feet Rhytid Study

NCT01892150Not ApplicableCompletedPrimary

Histologic Response to UVA and UVB Exposure During the Use of Sunscreen

Showing all 3 trials

Research Network

Common Treatments

  • Left Lateral Orbital Injection Of Botox Cosmetic Or Dysport1
  • Sunscreen1
  • Right Lateral Orbital Injection Of Botox Cosmetic Or Dysport1
  • Methylaminolevulinate Photodynamic Therapy1

Active Sponsors

  • University of Regensburg1
  • University of Sao Paulo1
  • Medicis Pharmaceutical Corporation1
  • The Maas Clinic1
  • Mahidol University1

Top Investigators

Related Conditions

  • Photoaging1
  • Actinic Keratosis1
  • Intrinsic Aging Of Skin1

Activity Timeline